These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Bioequivalence studies of pharmaceutical preparations]. Vetchý D; Frýbortová K; Rabisková M; Danecková H Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963 [TBL] [Abstract][Full Text] [Related]
28. Release of study ends drug fracas. Sternberg S Sci News; 1997 Apr; 151(16):236. PubMed ID: 11655105 [No Abstract] [Full Text] [Related]
29. [Preventable problems in thyroid hormone substitution therapy. The risks of brand change are unpredictable]. MMW Fortschr Med; 2010 Jun; 152(22):46-7. PubMed ID: 20590034 [No Abstract] [Full Text] [Related]
30. Generic levothyroxine. Med Lett Drugs Ther; 2004 Sep; 46(1192):77-8. PubMed ID: 15452463 [No Abstract] [Full Text] [Related]
31. Drug firm, relenting, allows unflattering study to appear. Altman LK N Y Times Web; 1997 Apr; ():A1, A16. PubMed ID: 11647207 [No Abstract] [Full Text] [Related]
32. Bioequivalence of oral products and the biopharmaceutics classification system: science, regulation, and public policy. Amidon KS; Langguth P; Lennernäs H; Yu L; Amidon GL Clin Pharmacol Ther; 2011 Sep; 90(3):467-70. PubMed ID: 21775984 [TBL] [Abstract][Full Text] [Related]
33. Publishing sensitive data: who calls the shots? Long-suppressed study finally sees light of day. Vogel G Science; 1997 Apr; 276(5312):525-6. PubMed ID: 9148408 [No Abstract] [Full Text] [Related]
34. Bioequivalence of levothyroxine preparations for treatment of hypothyroidism. Spigelman MK JAMA; 1997 Apr; 277(15):1199-200. PubMed ID: 9103337 [No Abstract] [Full Text] [Related]
35. I'm taking a generic version of Synthroid and I don't seem to feel as well as when I took the brand-name version. Is there a difference between the two? Mayo Clin Womens Healthsource; 2006 Feb; 10(2):10. PubMed ID: 16404339 [No Abstract] [Full Text] [Related]
36. Patient consent for publication and the health of the public. Snider DE JAMA; 1997 Aug; 278(8):624-6. PubMed ID: 9272883 [No Abstract] [Full Text] [Related]
37. Policy of AMA journals regarding release of information to the public. Lundberg GD; Glass RM; Joyce LE JAMA; 1991 Jan; 265(3):400. PubMed ID: 11642859 [No Abstract] [Full Text] [Related]
39. Japanese guidance on bioavailability and bioequivalence. Aoyagi N Eur J Drug Metab Pharmacokinet; 2000; 25(1):28-31. PubMed ID: 11032086 [TBL] [Abstract][Full Text] [Related]